The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2011

Filed:

Nov. 19, 2002
Applicants:

Marcello Allegretti, L'Aquila, IT;

Riccardo Bertini, L'Aquila, IT;

Cinzia Bizzarri, L'Aquila, IT;

Maria Candida Cesta, L'Aquila, IT;

Francesco Colotta, L'Aquila, IT;

Inventors:

Marcello Allegretti, L'Aquila, IT;

Riccardo Bertini, L'Aquila, IT;

Cinzia Bizzarri, L'Aquila, IT;

Maria Candida Cesta, L'Aquila, IT;

Francesco Colotta, L'Aquila, IT;

Assignee:

Dompe PHA.R.MA S.p.A., L'Aquila, IT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/192 (2006.01);
U.S. Cl.
CPC ...
Abstract

(R) and (S) 2-Aryl-propionic acids, and pharmaceutical compositions that contain them, are useful in inhibiting chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8) with CXCR1 and CXCR2 membrane receptors. The acids are used for the prevention and treatment of pathologies deriving from said activation. In particular, the (R) enantiomers of said acids are lacking cyclo-oxygenase inhibition activity and are particularly useful in the treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.


Find Patent Forward Citations

Loading…